Once primed by professional antigen-presenting cells in the lymph nodes, cancer-specific CD8+ T cells migrate into the tumor microenvironment (TME) to exert their cytolytic functions (1), where altered immunologic and metabolic cues interfere with CD8+ T-cell differentiation process and function (2, 3). This evidence concerns the gene CD8A and neoplasm.